Aptevo Therapeutics Statistics

Total Valuation

APVO has a market cap or net worth of $2.25 million. The enterprise value is $28,467.

Market Cap	2.25M
Enterprise Value	28,467

Important Dates

The next estimated earnings date is Tuesday, March 4, 2025, before market open.

Earnings Date	Mar 4, 2025
Ex-Dividend Date	n/a

Share Statistics

APVO has 500,326 shares outstanding.

Current Share Class	500,326
Shares Outstanding	500,326
Shares Change (YoY)	n/a
Shares Change (QoQ)	+199.68%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	6.31%
Float	474,899

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.47
P/TBV Ratio	0.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.70, with a Debt / Equity ratio of 1.25.

Current Ratio	1.70
Quick Ratio	1.32
Debt / Equity	1.25
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -250.96% and return on invested capital (ROIC) is -101.69%.

Return on Equity (ROE)	-250.96%
Return on Assets (ROA)	-72.75%
Return on Capital (ROIC)	-101.69%
Revenue Per Employee	n/a
Profits Per Employee	-$593,025
Employee Count	40
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -98.26% in the last 52 weeks. The beta is 5.10, so APVO's price volatility has been higher than the market average.

Beta (5Y)	5.10
52-Week Price Change	-98.26%
50-Day Moving Average	7.30
200-Day Moving Average	17.77
Relative Strength Index (RSI)	39.97
Average Volume (20 Days)	79,422

Short Selling Information

The latest short interest is 19,004, so 3.80% of the outstanding shares have been sold short.

Short Interest	19,004
Short Previous Month	241,678
Short % of Shares Out	3.80%
Short % of Float	4.00%
Short Ratio (days to cover)	0.04

Income Statement

Revenue	n/a
Gross Profit	-16.89M
Operating Income	-24.60M
Pretax Income	-24.95M
Net Income	-23.72M
EBITDA	-24.21M
EBIT	-24.60M
Earnings Per Share (EPS)	-$314.51

Full Income Statement

Balance Sheet

The company has $7.75 million in cash and $5.53 million in debt, giving a net cash position of $2.22 million or $4.44 per share.

Cash & Cash Equivalents	7.75M
Total Debt	5.53M
Net Cash	2.22M
Net Cash Per Share	$4.44
Equity (Book Value)	4.42M
Book Value Per Share	9.59
Working Capital	4.13M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-23.28M
Capital Expenditures	n/a
Free Cash Flow	-23.28M
FCF Per Share	-$46.53

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APVO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1,053.58%
FCF Yield	-1,033.95%

Analyst Forecast

The average price target for APVO is $296.00, which is 6,477.78% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$296.00
Price Target Difference	6,477.78%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 4, 2024. It was a reverse split with a ratio of 0.027027:1.

Last Split Date	Dec 4, 2024
Split Type	Reverse
Split Ratio	0.027027:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1